{"entity":{"type":"insider","cik":"0001649191","url":"/insider/0001649191","json_url":"/insider/0001649191.json","name":"Leber Laura","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2015-12-09","last":"2019-10-21","span_basis":"filed_date"},"name_variants":[{"name":"Leber Laura","source":"filing","n_filings":7,"first_seen":"2015-12-09","last_seen":"2019-10-21"}],"transactions":[{"id":8102658,"accession":"0001209191-19-053739","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-053739","line_url":"/filing/0001209191-19-053739#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13183.0,"shares_display":"13,183","price_per_share":70.942,"price_display":"70.94","price_state":"stated","total_value":935228.386,"total_display":"935,228.39","shares_owned_after":13736.0,"shares_owned_after_display":"13,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-17","filed_date":"2019-10-21","scope":"insider"},{"id":8312048,"accession":"0001209191-19-012803","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-012803","line_url":"/filing/0001209191-19-012803#line-7","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3817.0,"shares_display":"3,817","price_per_share":77.5706,"price_display":"77.57","price_state":"stated","total_value":296086.9802,"total_display":"296,086.98","shares_owned_after":17032.0,"shares_owned_after_display":"17,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider"},{"id":8312045,"accession":"0001209191-19-012803","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-012803","line_url":"/filing/0001209191-19-012803#line-6","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1067.0,"shares_display":"1,067","price_per_share":85.4661,"price_display":"85.47","price_state":"stated","total_value":91192.3287,"total_display":"91,192.33","shares_owned_after":21599.0,"shares_owned_after_display":"21,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider"},{"id":8312042,"accession":"0001209191-19-012803","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-012803","line_url":"/filing/0001209191-19-012803#line-5","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":86.3951,"price_display":"86.40","price_state":"stated","total_value":64796.325,"total_display":"64,796.32","shares_owned_after":20849.0,"shares_owned_after_display":"20,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider"},{"id":8312035,"accession":"0001209191-19-012803","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-012803","line_url":"/filing/0001209191-19-012803#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15479.0,"shares_display":"15,479","price_per_share":82.7382,"price_display":"82.74","price_state":"stated","total_value":1280704.5978,"total_display":"1,280,704.60","shares_owned_after":24120.0,"shares_owned_after_display":"24,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-22","scope":"insider"},{"id":8312029,"accession":"0001209191-19-012803","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-012803","line_url":"/filing/0001209191-19-012803#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3271.0,"shares_display":"3,271","price_per_share":83.4971,"price_display":"83.50","price_state":"stated","total_value":273119.0141,"total_display":"273,119.01","shares_owned_after":20849.0,"shares_owned_after_display":"20,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-22","scope":"insider"},{"id":6331300,"accession":"0001209191-18-012408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-012408","line_url":"/filing/0001209191-18-012408#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3174.0,"shares_display":"3,174","price_per_share":32.8936,"price_display":"32.89","price_state":"stated","total_value":104404.2864,"total_display":"104,404.29","shares_owned_after":16731.0,"shares_owned_after_display":"16,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-22","scope":"insider"},{"id":6331297,"accession":"0001209191-18-012408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-012408","line_url":"/filing/0001209191-18-012408#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":33.38,"price_display":"33.38","price_state":"stated","total_value":6676.0,"total_display":"6,676.00","shares_owned_after":16531.0,"shares_owned_after_display":"16,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-22","scope":"insider"},{"id":4838251,"accession":"0001209191-17-066235","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-066235","line_url":"/filing/0001209191-17-066235#line-4","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":315000.0,"total_display":"315,000.00","shares_owned_after":15754.0,"shares_owned_after_display":"15,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-15","filed_date":"2017-12-18","scope":"insider"},{"id":4838243,"accession":"0001209191-17-066235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-066235","line_url":"/filing/0001209191-17-066235#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":384000.0,"total_display":"384,000.00","shares_owned_after":15754.0,"shares_owned_after_display":"15,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-18","scope":"insider"},{"id":4444046,"accession":"0001209191-17-022285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-022285","line_url":"/filing/0001209191-17-022285#line-1","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3072.0,"shares_display":"3,072","price_per_share":31.8817,"price_display":"31.88","price_state":"stated","total_value":97940.5824,"total_display":"97,940.58","shares_owned_after":14627.0,"shares_owned_after_display":"14,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-22","scope":"insider"},{"id":2890590,"accession":"0001209191-16-151921","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-151921","line_url":"/filing/0001209191-16-151921#line-4","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3600.0,"shares_display":"3,600","price_per_share":31.7252,"price_display":"31.73","price_state":"stated","total_value":114210.72,"total_display":"114,210.72","shares_owned_after":17799.0,"shares_owned_after_display":"17,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-23","scope":"insider"},{"id":2890586,"accession":"0001209191-16-151921","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-151921","line_url":"/filing/0001209191-16-151921#line-3","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3468.0,"shares_display":"3,468","price_per_share":31.7346,"price_display":"31.73","price_state":"stated","total_value":110055.5928,"total_display":"110,055.59","shares_owned_after":14331.0,"shares_owned_after_display":"14,331","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-23","scope":"insider"},{"id":8582410,"accession":"0001209191-15-084208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-084208","line_url":"/filing/0001209191-15-084208#line-2","is_derivative":false,"issuer_cik":"0001131324","issuer_name":"GENOMIC HEALTH INC","issuer_ticker":"GHDX","issuer_name_source":null,"issuer_url":"/issuer/0001131324","owner_cik":"0001649191","owner_name":"Leber Laura","owner_url":"/insider/0001649191","role":"Officer (Chief Communication Officer)","officer_title":"Chief Communication Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":29.3337,"price_display":"29.33","price_state":"stated","total_value":123201.54,"total_display":"123,201.54","shares_owned_after":12959.0,"shares_owned_after_display":"12,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-07","filed_date":"2015-12-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001131324","name":"GENOMIC HEALTH INC","url":"/issuer/0001131324","role":"Officer (Chief Communication Officer)","n_filings":7,"first_seen":"2015-12-09","last_seen":"2019-10-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001649191","retrieved_at":"2026-08-22T00:11:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}